AI Generated Content

This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.

AstraZeneca gets CDSCO approval for Durvalumab in gastric cancer treatment

SUMMARY

AI Generated Content
  • AstraZeneca Durvalumab approved for gastric cancer.
  • Combination therapy targets resectable gastric cancer.
  • New immunotherapy approach improves survival.
AD
Other Interesting Stories
AD